Stock Market & Financial Investment News

News Breaks March 15, 2013 06:38 EDT OMPI Obagi Medical upgraded to Buy from Hold at Cantor Cantor upgraded Obagi Medical following the company's Q4 results and raised its price target for shares to $19 from $15. The firm sees a 50% probability of company takeout in the $21 per share range. News For OMPI From The Last 14 Days Check below for free stories on OMPI the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for OMPI Sign up for a free trial to see the rest of the stories you've been missing.